NEW YORK, NY--(Marketwire - December 02, 2008) - The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a biotechnology founder's grant of $300,000 to P2D Biosciences (P2D), a start-up biotechnology company dedicated to developing drugs that prevent Alzheimer's disease (AD).
